CRH PLC/ IE0001827041 /
9/8/2023 5:27:59 PM | Chg. -0.02 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
50.92EUR | -0.04% | 248,416 Turnover: 12.6 mill. |
-Bid Size: - | -Ask Size: - | 54.1 bill.EUR | - | - |
GlobeNewswire
3/28
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire
3/14
HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI...
GlobeNewswire
2/26
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
GlobeNewswire
2/12
Martin Marietta Announces Acquisition of Aggregates Operations From Affiliates of Blue Water Industr...
GlobeNewswire
1/30
Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
GlobeNewswire
12/18/2023
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
GlobeNewswire
12/11/2023
Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (lu...
GlobeNewswire
12/11/2023
Cogent Biosciences Announces Positive Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib ...
GlobeNewswire
11/21/2023
Martin Marietta to Divest South Texas Cement and Related Concrete Operations to CRH plc
GlobeNewswire
11/14/2023
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
10/30/2023
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug ...
GlobeNewswire
10/27/2023
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
GlobeNewswire
10/23/2023
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
GlobeNewswire
10/16/2023
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th Int...